Revive Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Revive Therapeutics has a total shareholder equity of CA$7.2M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$10.6M and CA$3.4M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
| Interest coverage ratio | n/a |
| Cash | CA$773.07k |
| Equity | CA$7.23m |
| Total liabilities | CA$3.40m |
| Total assets | CA$10.64m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 31R's short term assets (CA$1.1M) do not cover its short term liabilities (CA$3.3M).
Long Term Liabilities: 31R's short term assets (CA$1.1M) exceed its long term liabilities (CA$79.9K).
Debt to Equity History and Analysis
Debt Level: 31R is debt free.
Reducing Debt: 31R had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 31R has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 31R has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.1% each year